News
-
IHU PRISM, a precision medicine institute (France), interview with Dr. Maud Kamal
22 April 2025 – Dr. Maud Kamal, introduced the IHU PRISM, the first National Centre for Precision Medicine in oncology in France launched in 2020 and labelled « Institut Hospitalo-Universitaire » (IHU) by the French Government as part of the France 2030 Plan. In the frame of the ICPerMed Strategic Working Group on Internationalisation, Dr.…
-
France improves the validation and implementation of medical diagnostics innovation
15 April 2025 – Since the launch of the Health Innovation 2030 plan, France is investing in the development and validation of innovative in vitro and companion diagnostics. This will support the implementation of personalised medicine approaches and accelerate the decision on reimbursement. The development of in vitro and companion diagnostics is a key determinant…
-
Center for Precision Medicine of the University Hospital Brno (Czech Republic), interview with Prof. Ondrej Slaby
09 April 2025 – In the frame of the ICPerMed Strategic Working Group on Internationalisation, Prof. Ondrej Slaby, Head of the Center for Precision Medicine and also the chairperson of the Czech Health Research Council, has presented the Center for Precision Medicine of the University Hospital Brno which was established in May 2024. The center…
-
New publication: 2025 France Genomic Medicine Initiative
08 April 2025 – The “2025 France Genomic Medicine Initiative” is one of the Best Practice Examples recognised by ICPerMed. It is designed to introduce genome sequencing into the care pathway, starting with the prescription of genome analysis until the medical report. A new publication from the initiative is just available: https://pfmg2025.fr/publications/
-
ICPerMed White Paper on Value and Evaluation of Personalised Medicine published
07 April 2025 – The International Consortium for Personalised Medicine (ICPerMed) has published a new White Paper on “the Value and Evaluation of Personalised Medicine”. Over a period of three years, the ICPerMed Health Economic Working Group has led a workshop and other activities to explore the health economic aspects of Personalised Medicine approaches. The…
-
Success Stories for African-European Collaboration in Personalised Medicine published
17 January 2025 – EU-Africa PerMed, a project of the ICPerMed Family, has identified and is showcasing success stories of African-European research collaborations in personalised medicine. Through real case examples, EU-Africa PerMed presents compelling narratives that illustrate the tangible benefits of international collaboration in personalised medicine and offers valuable insights to policymakers, patients, clinicians, and…
-
PERMIT Guidelines for designing and implementing all Stages of Personalised Medicine Research
17 January 2025 – The ICPerMed Family project PERMIT (PERsonalised MedicIne Trials) has published new recommendations ensuring the robustness of personalised medicine research programmes, throughout the personalised medicine pipeline.
-
The Ministry of Higher Education and Scientific Research of Tunisia joins ICPerMed
07 November 2024 – ICPerMed welcomes the Ministry of Higher Education and Scientific Research (MHESR) as new member.
-
Webinar on Collaboration to Increase Patient Involvement in Personalised Medicine – Lessons from Nigeria, Hungary, and Perspective from Europe
21 October 2024 – On 29 October 2024, from 16:00 to 17:30h, the EU-Africa PerMed consortium in collaboration with From Testing to Targeted Treatments (FT3) organises a webinar that will explore practical strategies for improving patient involvement and shared decision-making in healthcare. Real-world case studies from Nigeria and Hungary will highlight how these initiatives are…
-
Draft Strategic Research and Innovation Agenda for Personalised Prevention
01 October 2024 – The first draft of the Strategic Research and Innovation Agenda (SRIA) for Personalised Prevention of the ICPerMed Family project PROPHET was presented to invited experts at the Nanna Svartz Auditorium, BioClinicum, in Stockholm.
The International Consortium for Personalised Medicine (ICPerMed) brings together almost 50 European and international partners representing ministries, funding agencies and the European Commission (EC). Together, they work on coordinating and fostering research to develop and evaluate personalised medicine approaches.
To find out more about ICPerMed, listen to the people involved in the following video, recorded during the recent ICPerMed Workshop 2023.
What is the International Consortium for Personalised Medicine (ICPerMed)? What is the ICPerMed Family? What are our activities? How can you get in contact with us? How does the ICPerMed microcosm aim to foster the development of Personalised Medicine?
ICPerMed Workshop ‘Advancing Personalised Medicine through Technology Development’
On 14 and 15 November 2023, ICPerMed organised the 5th ICPerMed Workshop, which focused on and explored the latest developments in technology and innovation driving the field of personalised medicine. The workshop took place in Siena (Italy) and aimed to showcase experiences of researchers, clinicians, biotech and industry leaders, to provide insights on how to drive personalised medicine related innovations in the healthcare sector, and to present selected and promising technologies/tools.
The European Partnership for Personalised Medicine (EP PerMed) fosters collaboration and networking in all areas of personalised medicine between healthcare providers, researchers, citizens, payers and industry to accelerate the development and translation of personalised medicine approaches into healthcare, clinical applications and prevention. EP PerMed acts as a coordination and funding platform, bringing together more than 50 European national ministries and funding agencies in the Research Area for Health and Wellbeing. In addition, several regional authorities and government departments such as ministries of health, research, innovation and education have already joined.